Amphastar Pharmaceuticals
AMPH
#5787
Rank
โ‚น111.65 B
Marketcap
โ‚น2,618
Share price
0.50%
Change (1 day)
16.62%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): โ‚น159.92

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น161.25. In 2025 the company made an earnings per share (EPS) of โ‚น194.61 a decrease over its 2024 EPS that were of โ‚น304.88.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น159.92-17.82%
2025โ‚น194.61-36.17%
2024โ‚น304.8815.85%
2023โ‚น263.1851.87%
2022โ‚น173.2943.85%
2021โ‚น120.473521.88%
2020โ‚น3.33-96.55%
2019โ‚น96.38-900%
2018-โ‚น12.05-238.6%
2017โ‚น8.69-60.92%
2016โ‚น22.24
2014-โ‚น22.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
-โ‚น1,199-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-โ‚น481.88-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-โ‚น216.85-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚น358.63-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA